Edition:
India

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.71USD
9:09pm IST
Change (% chg)

$0.00 (+0.01%)
Prev Close
$0.71
Open
$0.70
Day's High
$0.73
Day's Low
$0.67
Volume
12,332
Avg. Vol
60,363
52-wk High
$1.52
52-wk Low
$0.62

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

18 Apr 2018

BRIEF-Regulus Qtrly Net Loss Per Share $0.14

* REGULUS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PIPELINE UPDATE

08 Mar 2018

BRIEF-Regulus Therapeutics Files For Mixed Shelf Of Up To $150 Mln

* REGULUS THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING‍​ Source text: (http://bit.ly/2rQDgcO) Further company coverage:

29 Jan 2018

Competitors

Earnings vs. Estimates